• Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Home > Publishers > GBI Research
Publisher
Filter

GBI Research Report List

GBI Research provides industry-leading global business intelligence solutions. Our products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports per annum across a wide range of industries. Our reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from our expert teams. GBI Research employs hundreds of highly qualified Analysts across the US, Europe and Asia. Key report types currently published by GBI Research include: ? Market Intelligence Reports: premium analytical reports based on a combination of market data, company, deals and project content, industry surveys and additional primary and secondary research. ? Benchmarking Reports: analytical reports comparing key financial indicators for the top 20 companies in a particular industry and geography. ? Industry Outlook Reports: survey-based reports, revealing and analyzing the leading experts' opinions on the future of the industry covered. ? Market Profiles: overview-level reports based on market, company and demographic data. ? Pipeline Analysis Reports: reports analyzing the unmet need, market size and product pipeline for different disease indications, based on a detailed database of developmental products.

New for 2017!
Filter
Title Search
1 - 25 of 135 Products Sort by Display
Antibacterial Therapies Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
485008
Published
March 22, 2017
Content info
418 Pages
Price
USD 3995
Sample available
Neurodegenerative Disorders Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
489881
Published
March 21, 2017
Content info
797 Pages
Price
USD 3995
Sample available
Cardiovascular Disorders Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
485009
Published
March 16, 2017
Content info
432 Pages
Price
USD 3995
Sample available
Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market
Published by
GBI Research
Product code
358649
Published
March 9, 2017
Content info
161 Pages
Price
USD 4995
Sample available
Frontier Pharma: Head and Neck Cancer - Immunotherapies and Signal Transduction Inhibitors Dominate First-in-Class Innovation
Published by
GBI Research
Product code
485007
Published
March 1, 2017
Content info
78 Pages
Price
USD 6995
Sample available
Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market
Published by
GBI Research
Product code
485006
Published
March 1, 2017
Content info
197 Pages
Price
USD 4995
Sample available
Colorectal Cancer - Heat Map and Analysis
Published by
GBI Research
Product code
445728
Published
February 1, 2017
Content info
21 Pages
Price
USD 2000
Sample available
Parkinson's Disease - Heat Map and Analysis
Published by
GBI Research
Product code
440736
Published
January 9, 2017
Content info
20 Pages
Price
USD 2000
Sample available
Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance
Published by
GBI Research
Product code
440734
Published
January 9, 2017
Content info
177 Pages
Price
USD 4995
Sample available
Non-Hodgkin Lymphoma - Heat Map and Analysis
Published by
GBI Research
Product code
440735
Published
January 6, 2017
Content info
15 Pages
Price
USD 2000
Sample available
Frontier Pharma: Versatile Innovation in Immunology - Large Therapy Area Pipeline with a High Degree of Repositioning Potential
Published by
GBI Research
Product code
440733
Published
January 5, 2017
Content info
80 Pages
Price
USD 6995
Sample available
Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies
Published by
GBI Research
Product code
431673
Published
January 2, 2017
Content info
108 Pages
Price
USD 4995
Sample available
Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation
Published by
GBI Research
Product code
431672
Published
January 2, 2017
Content info
81 Pages
Price
USD 6995
Sample available
COPD Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies
Published by
GBI Research
Product code
423017
Published
January 1, 2017
Content info
122 Pages
Price
USD 4995
Sample available
Dermatology Therapeutics Drug Development Pipeline Review, 2016
Published by
GBI Research
Product code
445727
Published
December 15, 2016
Content info
432 Pages
Price
USD 3995
Sample available
Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations
Published by
GBI Research
Product code
410321
Published
December 1, 2016
Content info
65 Pages
Price
USD 6995
Sample available
Global Cancer Immunotherapies Market to 2022 - Immune Checkpoint Inhibitors and Therapeutic Cancer Vaccines to Characterize Increasingly Competitive Market
Published by
GBI Research
Product code
410320
Published
December 1, 2016
Content info
363 Pages
Price
USD 4995
Sample available
Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects
Published by
GBI Research
Product code
409707
Published
December 1, 2016
Content info
88 Pages
Price
USD 6995
Sample available
Diabetes & Obesity Drug Development Pipeline Review, 2016
Published by
GBI Research
Product code
397899
Published
December 1, 2016
Content info
560 Pages
Price
USD 3995
Sample available
Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2022 - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline
Published by
GBI Research
Product code
336890
Published
December 1, 2016
Content info
110 Pages
Price
USD 4995
Sample available
Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments
Published by
GBI Research
Product code
219212
Published
December 1, 2016
Content info
133 Pages
Price
USD 4995
Sample available
Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19
Published by
GBI Research
Product code
399713
Published
November 1, 2016
Content info
183 Pages
Price
USD 4995
Sample available
Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation
Published by
GBI Research
Product code
399712
Published
November 1, 2016
Content info
61 Pages
Price
USD 6995
Sample available
Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy
Published by
GBI Research
Product code
399711
Published
November 1, 2016
Content info
126 Pages
Price
USD 4995
Sample available
Ophthalmology Drug Development Pipeline Review, 2016
Published by
GBI Research
Product code
397898
Published
November 1, 2016
Content info
633 Pages
Price
USD 3995
Sample available